Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[A case of hepatitis B virus/human immunodeficiency virus coinfection in a patient who achived hepatitis B surface antigen seroclearance after interferon therapy followed by antiretroviral therapy without developing immune reconstitution inflammatory syndrome].
Mitsumoto F, Murata M, Ikezaki H, Ogawa E, Taniai H, Toyoda K, Otaguro S, Kainuma M, Okada K, Furusyo N, Hayashi J. Mitsumoto F, et al. Kansenshogaku Zasshi. 2012 Nov;86(6):763-7. doi: 10.11150/kansenshogakuzasshi.86.763. Kansenshogaku Zasshi. 2012. PMID: 23367852 Japanese.
A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
Murata M, Furusyo N, Ogawa E, Mitsumoto F, Hiramine S, Ikezaki H, Takayama K, Shimizu M, Toyoda K, Kainuma M, Hayashi J. Murata M, et al. Among authors: mitsumoto f. J Infect Chemother. 2014 May;20(5):320-4. doi: 10.1016/j.jiac.2013.11.006. Epub 2014 Jan 27. J Infect Chemother. 2014. PMID: 24477330
Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response.
Furusyo N, Ogawa E, Murata M, Toyoda K, Ohnishi H, Eiraku K, Shimizu M, Harada Y, Mitsumoto F, Takayama K, Kainuma M, Okada K, Hayashi J. Furusyo N, et al. Among authors: mitsumoto f. J Antimicrob Chemother. 2014 Feb;69(2):483-90. doi: 10.1093/jac/dkt371. Epub 2013 Oct 3. J Antimicrob Chemother. 2014. PMID: 24092661 Clinical Trial.
Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: results from the Kyushu and Okinawa Population Study (KOPS).
Shimizu M, Furusyo N, Mitsumoto F, Takayama K, Ura K, Hiramine S, Ikezaki H, Ihara T, Mukae H, Ogawa E, Toyoda K, Kainuma M, Murata M, Hayashi J. Shimizu M, et al. Among authors: mitsumoto f. Atherosclerosis. 2015 Feb;238(2):207-12. doi: 10.1016/j.atherosclerosis.2014.12.013. Epub 2014 Dec 9. Atherosclerosis. 2015. PMID: 25528429
Glycated albumin as a diagnostic tool for diabetes in a general Japanese population.
Ikezaki H, Furusyo N, Ihara T, Hayashi T, Ura K, Hiramine S, Mitsumoto F, Takayama K, Murata M, Kohzuma T, Ai M, Schaefer EJ, Hayashi J. Ikezaki H, et al. Among authors: mitsumoto f. Metabolism. 2015 Jun;64(6):698-705. doi: 10.1016/j.metabol.2015.03.003. Epub 2015 Mar 14. Metabolism. 2015. PMID: 25817605
12 results